Article
Structure-based discovery of CFTR potentiators and inhibitors
28 May 2024
Abstract excerpt
The cystic fibrosis transmembrane conductance regulator (CFTR) is a crucial ion channel whose loss of function leads to cystic fibrosis, whereas its hyperactivation leads to secretory diarrhea. Small molecules that improve CFTR folding (correctors) or function (potentiators) are clinically available. However, the only potentiator, ivacaftor, has suboptimal pharmacokinetics and inhibitors have yet to be clinically...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
